Soligenix
SNGX
#11002
Rank
HK$57.17 M
Marketcap
HK$2.63
Share price
0.51%
Change (1 day)
-75.16%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2023 (TTM): -HK$20.84

According to Soligenix's latest financial reports the company's current EPS (TTM) is -HK$14.11. In 2022 the company made an earnings per share (EPS) of -HK$34.73 a decrease over its 2021 EPS that were of -HK$33.10.

EPS history for Soligenix from 1998 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.84-40%
2022-HK$34.734.93%
2021-HK$33.10-58%
2020-HK$78.8136.73%
2019-HK$57.63-33.78%
2018-HK$87.04-36.75%
2017-HK$137.6227.17%
2016-HK$108.21-70.23%
2015-HK$363.45-3.44%
2014-HK$376.39-45.76%
2013-HK$693.9659.46%
2012-HK$435.2060.87%
2011-HK$270.53-68.49%
2010-HK$858.63-8.75%
2009-HK$940.96100%
2008-HK$470.48-71.43%
2007-HK$1,647-46.15%
2006-HK$3,05862.5%
2005-HK$1,882-52.94%
2004-HK$3,999-22.73%
2003-HK$5,175-24.14%
2002-HK$6,822-75.63%
2001-HK$27,994138%
2000-HK$11,762-39.76%
1999-HK$19,525-62.61%
1998-HK$52,223

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42-471.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.96-142.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.92-205.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-HK$7.45-47.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$15.92 12.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-135.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
-HK$26.97 91.11%๐Ÿ‡บ๐Ÿ‡ธ USA